Ultimele actualizari :
07/07/2025
Echipe de cercetare - Quality Evaluation Team, Samsung Bioepis Co   pdf  
Japonia
laboratoare farmaceutice
Quality Evaluation Team, Samsung Bioepis Co
Incheon
Bibliografie   Bibliografie   (5)  
1
In‑Use Stability of SB12 (Eculizumab, Soliris Biosimilar) Diluted in Saline and Dextrose Infusion Solution after an Extended Storage Period.
Tak M, Jeong H, Yun J, Kim J, Kim S, Lee Y, Park S-J. (sujin8171.park@samsung.com)
Drugs R D - 2023 - ;23,4:363 - 375
2
Physicochemical and Biological Stability Assessment of SB11 (Ranibizumab Biosimilar) Under Ambient and In-Use Storage for Intravitreal Administration.
Kaiser P.K, Yun J, Kim S, Kim J, Park S.J. (sujin8171.park@samsung.com)
Ophtalmol Ther - 2023 - ; 12:985–998.
3
4
Extended Stability of Reconstituted and Diluted SB3 (Trastuzumab Biosimilar) Assessed by Physicochemical and Biological Properties
Yun J, Kim J, Chung J, Hwang S-J, Park S-J. (sujin8171.park@samsung.com)
Adv Ther - 2019 -
5
Evaluation of Physicochemical and Biological Stability of 36-Months-Aged SB5 (Adalimumab Biosimilar) for 4 Weeks at Room Temperature.
Park D, Yun J, Hwang S-J, Park SJ. (sujin8171.park@samsung.com)
Adv Ther - 2019 - 36:442–450

Listele    molecule studiate   (5)  
Imunosupresor Injectabil Adalimumab
Citostatic Injectabil Bevacizumab
Diverse Injectabil Eculizumab
Diverse Injectabil Ranibizumab
Citostatic Injectabil Trastuzumab

  Mentions Légales
BESbswy